Yuyu Pharma Inc
KRX:000225
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Yuyu Pharma Inc
KRX:000225
|
KR |
|
A
|
AMAG Austria Metall AG
XBER:AM8
|
AT |
|
Shift Technologies Inc
OTC:SFTGQ
|
US |
|
S
|
Sound Energy PLC
OTC:SNEGF
|
UK |
|
A
|
Adhi Karya (Persero) Tbk PT
XMUN:KM6
|
ID |
|
Futaba Corp
OTC:FUBAF
|
JP |
|
F
|
First Guaranty Bancshares Inc
F:1GJ
|
US |
|
N
|
Neogen Corp
F:NG2
|
US |
|
O
|
Ora Gold Ltd
XMUN:TJ3
|
AU |
|
Iida Group Holdings Co Ltd
F:IIO
|
JP |
|
Enzon Pharmaceuticals Inc
OTC:ENZND
|
US |
|
Yamaguchi Financial Group Inc
F:5FW
|
JP |
|
Sparc Technologies Ltd
OTC:SPTCF
|
AU |
|
W
|
Western Magnesium Corp
OTC:MLYF
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Yuyu Pharma Inc's stock price target?
Not Available
Yuyu Pharma Inc does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Yuyu Pharma Inc?
Projected CAGR
-6%
Over the last 7 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is -6%.
What is the Gross Profit forecast for Yuyu Pharma Inc?
Projected CAGR
-2%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 5 years is -2%.
What is the Operating Income forecast for Yuyu Pharma Inc?
Projected CAGR
-6%
Over the last 7 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 5 years is -6%.
What is the Pre-Tax Income forecast for Yuyu Pharma Inc?
Projected CAGR
-9%
Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 5 years is -9%.
What is the Net Income forecast for Yuyu Pharma Inc?
Projected CAGR
-12%
Over the last 7 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 5 years is -12%.
